Table 1 Clinical characteristics, treatment, and follow-up of 17 patients with sinusoidal large B-cell lymphoma.
From: The clinicopathological and molecular features of sinusoidal large B-cell lymphoma
Patient | Age (years) | Sex | Presentation site | B symptoms | Serum LDH(IU/L) | Stage | PS | Number of extranodal sites | IPI score | Chemotherapy | Response | Survival (mo) | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 43 | M | Cervical LN | No | Normal | II | 2 | 2 | 2 | R-CHOP | CR | 50 | Alive |
2 | 48 | M | Axillary LN | Yes | Elevated | IV | 3 | 2 | 4 | R-CHOP | PD | 8 | Dead |
3 | 57 | M | Inguinal LN | No | Normal | II | 2 | 2 | 2 | R-CHOP | PR | 13 | Dead |
4 | 55 | M | Cervical LN | Yes | Elevated | III | 3 | 3 | 4 | R-CHOP | PR | 11 | Dead |
5 | 48 | F | Cervical LN | Yes | Elevated | II | 2 | 1 | 2 | R-CHOP | PR | 50 | Alive |
6 | 56 | F | Cervical LN | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
7 | 54 | F | Cervical LN | No | Normal | II | 2 | 2 | 2 | R-CHOP | CR | NA | NA |
8 | 63 | F | Cervical LN | Yes | Elevated | III | 1 | 1 | 3 | R-CHOP | CR | 32 | Dead |
9 | 66 | F | Cervical LN | Yes | Elevated | IV | 3 | 3 | 5 | R-CHOP | PD | 9 | Dead |
10 | 52 | F | Supraclavicular LN | No | Normal | III | 1 | 2 | 2 | R-CHOP | CR | 18 | Dead |
11 | 74 | F | Cervical LN | Yes | Elevated | IV | 1 | 3 | 4 | R-CHOP | PR | 16 | Dead |
12 | 73 | M | Cervical LN | Yes | Elevated | IV | 1 | 3 | 4 | R-CHOP | PR | 20 | Dead |
13 | 80 | M | Inguinal LN | Yes | Elevated | III | 4 | 2 | 5 | R-CHOP | PD | 4 | Dead |
14 | 64 | F | Cervical LN | No | Elevated | IV | 1 | 3 | 4 | R-CHOP | PR | 35 | Dead |
15 | 50 | F | Supraclavicular LN | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
16 | 67 | M | Submandibular LN | No | Elevated | III | 1 | 1 | 3 | R-CHOP | CR | 12 | Alive |
17 | 57 | F | Cervical LN | Yes | Elevated | IV | 2 | 1 | 3 | NA | NA | NA | NA |
